Pardes Biosciences Inc (PRDS)
followers
·
Follow
| Sector: | FINANCE |
| Industry: | GENERAL FINANCE |
| CEO: | Thomas G. Wiggans |
| Employees: | 30 |
| Web site: | pardesbio.com |
|
2173 SALK AVENUE, SUITE 250, PMB#052, CARLSBAD, CA, 92008
415-649-8758
| |
• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know
-
Formally known as:
- FS Development Corp II
Are you looking for this stock instead?
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
Pardes Biosciences, Inc. focuses on discovering, developing, and commercializing novel therapeutics. Its lead candidate is the PBI-0451 that is in clinical development stage to treat and prevent severe acute respiratory syndrome coronavirus 2 infections and associated diseases.